Association between in utero zidovudine exposure and nondefect adverse birth outcomes: analysis of prospectively collected data from the Antiretroviral Pregnancy Registry

BJOG. 2016 May;123(6):910-6. doi: 10.1111/1471-0528.13542. Epub 2015 Aug 12.

Abstract

Objective: To examine the association between nondefect adverse birth outcomes and in utero exposure to zidovudine (ZDV)-containing regimens versus non-ZDV antiretroviral (ARV) regimens.

Design: Analysis of prospectively-collected data.

Setting: Global.

Population: HIV-infected pregnant women prenatally exposed to antiretrovirals.

Methods: Estimation of prevalence of and risk for nondefect adverse birth outcomes among HIV-infected women.

Main outcome measures: Prevalence of and risk for nondefect adverse birth outcomes.

Results: Among 12 780 singleton birth outcomes with in utero ZDV exposure, 96.1% were live births; 3.9% were spontaneous abortions, induced abortions or stillbirths. Among live births, 16.4% were low birthweight (LBW); 12.3% were premature. Among 1904 outcomes with in utero exposure to non-ZDV ARV regimens, 85.8% were live births; 14.2% were spontaneous abortions, induced abortions or stillbirths. Among live births, 14.1% were LBW; 12.4% were premature. Relative risk comparing exposure to ZDV-containing ARV regimens to non-ZDV ARV regimens for spontaneous abortions was 0.18 (95% confidence interval [95% CI] 0.14-0.22); induced abortions 0.28 (95% CI 0.22-0.36); stillbirths 0.76 (95% CI 0.51-1.12); premature births 1.00 (95% CI 0.87-1.15) and LBW 1.17 (95% CI 1.02-1.33).

Conclusion: Prevalence of nondefect adverse birth outcomes is lower among outcomes with in utero ZDV exposure versus in utero non-ZDV ARV exposure. The risks for spontaneous and induced abortions were no different for ZDV-containing regimens versus non-ZDV ARV regimens. For premature births and stillbirths, there was no significant difference in risk between the two regimens. The risk of LBW was statistically significantly higher among ZDV-containing regimens versus non-ZDV ARV regimens.

Tweetable abstract: ZDV-containing regimens do not increase the risk for nondefect adverse birth outcomes.

Trial registration: ClinicalTrials.gov NCT01137981.

Keywords: Epidemiology HIV; pregnancy outcomes; zidovudine.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Abortion, Induced / statistics & numerical data
  • Abortion, Spontaneous / epidemiology*
  • Adolescent
  • Adult
  • Anti-HIV Agents / administration & dosage*
  • Anti-HIV Agents / adverse effects
  • Female
  • HIV Infections / drug therapy*
  • Humans
  • Infant, Low Birth Weight
  • Live Birth
  • Middle Aged
  • Pregnancy
  • Pregnancy Complications, Infectious / drug therapy*
  • Premature Birth / epidemiology
  • Prenatal Exposure Delayed Effects / epidemiology*
  • Prevalence
  • Registries
  • Risk Factors
  • Stillbirth / epidemiology*
  • Young Adult
  • Zidovudine / administration & dosage*
  • Zidovudine / adverse effects

Substances

  • Anti-HIV Agents
  • Zidovudine

Associated data

  • ClinicalTrials.gov/NCT01137981